Lps derived from escherichia coli serotype 0111 b4
LPS derived from Escherichia coli (serotype 0111:B4) is a laboratory product manufactured by Merck Group. It is a lipopolysaccharide molecule extracted from the outer membrane of the Gram-negative bacterium Escherichia coli, specifically the 0111:B4 serotype. The core function of this product is to serve as a research tool for scientific investigations, without further interpretation or extrapolation on its intended use.
Lab products found in correlation
3 protocols using lps derived from escherichia coli serotype 0111 b4
Mice Models for CD1d Deficiency
Murine Colitis Induction and Immune Profiling
Experimental Mice Maintenance and Handling
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!